EDITORIAL: An opportunity for bipartisanship on Medicare drug prices
One reason for America's high cost of health care is that many medicines are much more expensive here than abroad. In fact, an analysis by the
A report this year from Medicare trustees said parts of the program are heading toward insolvency by 2026. That dismal prospect is three years earlier than previously projected.
The Trump administration wants to bring down those Medicare drug prices, keeping them more in line with prices charged abroad. A similar plan floated by the Obama administration drew fierce opposition and was shelved.
Yet if President
The administration's proposed Medicare model would use the International Pricing Index to limit prices for Medicare Part B drugs that must be administered in doctors' offices or hospitals. These include medications for cancer, arthritis and a host of other diseases. Spending on such Part B drugs has doubled since 2006, according to
The Trump administration would phase in that Plan B drug pricing over five years, cutting costs by 30 percent -- a projected savings of
In general, Medicare Part B currently reimburses for the average cost of a drug plus 6 percent for the health provider's cost of administering it. Critics say the 106 percent reimbursement creates an incentive to use the most expensive drugs.
Fair enough, but that margin also enables some independent medical practitioners to stay in business.
The challenge is to reform drug pricing in ways that neither stifle competition nor prevent patients from receiving the most effective medications.
In addition, the pharmaceutical companies deserve a reasonable return on their research and development investment. But what is reasonable, and how much of it should come from Americans? Trump contends foreign medical systems are freeloaders, negotiating lower drug prices while Americans wind up subsidizing the drugs' development.
In describing the proposal,
There are many variables across national lines that limit the validity of these sorts of analyses, but the researchers' bottom line was direct: Higher
That reality should galvanize action across party lines. America is as far from national elections as it gets. It's the perfect time for bold measures to control health care costs.
___
(c)2018 The Press Democrat (Santa Rosa, Calif.)
Visit The Press Democrat (Santa Rosa, Calif.) at www.pressdemocrat.com
Distributed by Tribune Content Agency, LLC.


Top Benefits Provided By Online Car Insurance Quotes
In NC, nonprofits have become the ‘backbone of disaster recovery’
Advisor News
- Semi-retirement: helping clients balance flexibility with financial security
- The 6X Formula for leveraging content marketing with AI
- When a home becomes difficult to insure, the plan changes
- The inheritance gap: Helping clients plan for money that hasn’t arrived
- After the midterms: Addressing your clients’ tax concerns
More Advisor NewsAnnuity News
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
- John Hancock launches new fixed indexed annuity suite
- Annuities to play a larger role in workplace retirement plans
- FHLBank Pittsburgh Announces Results in 2026 Board Election
More Annuity NewsHealth/Employee Benefits News
- Patients with 3 health insurance plans lose access to Miami health network
- Weld County deputy struggling after being injured by DUI driver (photo gallery)
- Changes to Medicare Advantage plan offerings affect Montana seniors
- Medicaid work rules don’t apply to Native Americans. They could still lose coverage.
- Native Americans face Medicaid exemption hurdles
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
- Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
- Military Briefs: November 12-18
- Security Benefit Series B Preferred Stock Dividend Rate Resets to 10.286%
- FHLBank Pittsburgh Announces Results in 2026 Board Election
More Life Insurance News